Bioclinitech Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -1.28%
- Profit Growth -8.95%
- Ebitda -4.69%
- Net Worth 8.02%
- Total Assets 17.32%
About Bioclinitech Technologies
Bioclinitech Technologies Private Limited (BTPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2005 and has a history of 20 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Pol and Manish Arora serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85120MH2005PTC150662
- Company No.
150662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bioclinitech Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Pol  | Director | 25-Mar-2019 | Current |
| Manish Arora | Additional Director | 21-Feb-2017 | Current |
Financial Performance of Bioclinitech Technologies.
Bioclinitech Technologies Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 1.28% decrease. The company also saw a slight decrease in profitability, with a 8.95% decrease in profit. The company's net worth moved up by a moderate rise of 8.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioclinitech Technologies?
In 2017, Bioclinitech Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krizantem-World Homestay Private LimitedPramod Pol is a mutual person
- Inovatsia Consulting Services Private Limited
Pramod Pol is a mutual person
- Artemia - Gmm Impex Private Limited
Pramod Pol is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioclinitech Technologies?
Unlock and access historical data on people associated with Bioclinitech Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioclinitech Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioclinitech Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
